If Obamacare enrollments continue their current trend and insurers continue to hike premiums at alarming rates then Republicans may not have to worry about "repealing and replacing Obamacare" as it might just work itself out "naturally". The 4th open enrollment period for Obamacare begins on November 1, 2016 and industry experts are warning that another year of tepid demand from "young and healthy" Americans could force more insurers out of the exchanges effectively marking the end of Obamacare as we know it. Accord
An investigation in California over dramatic health insurance increases is spurring a federal inquiry. Two congressional committees have asked executives from WellPoint, the parent company of Anthem Blue Cross of California, to explain why the company is raising premiums by as much as 39 percent for some customers.
Express Scripts Holding Co. (NASDAQ:ESRX) fell as much as 7.6% during yesterday\'s trade when Anthem Inc. (NYSE:ANTM), its largest client, threatened to ditch the pharmacy benefit manager (PBM) unless it delivers cost savings of as much as $3 billion annually.
WASHINGTON (AP) — The leaders of two major health insurers planning separate multi-billion dollar acquisitions made the case for the deals to Congress as senators questioned whether they would hurt competition and raise prices for consumers.Blue Cross-Blue Shield insurer Anthem plans to buy Cigna for $48 billion, and rival Aetna is looking to buy Medicare Advantage coverage provider Humana for $35 billion. As a wave of consolidation sweeps through the industry, the deals came under scrutiny at a Senate Judiciary subcommittee hearing Tuesday.
Anthem Inc said on Friday it would buy Cigna Corp in a deal valued at US$54.2 billion, creating the largest U.S. health insurer by membership.
The deal – the biggest ever in the health insurance industry – comes three weeks after Aetna Inc agreed to buy Humana Inc for US$37 billion and is part of an industry-wide consolidation following the roll-out of President Barack Obama’s healthcare law.
Antitrust authorities are expected to aggressively scrutinize how the combinations will affect competition for Medicare and individual and commercial insurance.